Popular Articles

Elbit Imaging Ltd. Announces Swiss Team Uses InSightec's ExAblate(R) 4000 Brain System To Treat Patients With Functional Brain Disorders
Elbit Imaging Ltd. (TASE: EMIT, Nasdaq: EMITF), announced that, its subsidiary (in which EI holds indirectly approximately 58.34%, InSightec Ltd., announced that a team at the University Children"s Hospital Zurich has completed a feasibility study testing the use of non-invasive transcranial MR-guided focused ultrasound surgery (TcMRgFUS) for the treatment of neuropathic pain. Ten adult patients diagnosed with chronic neuropathic pain successfully underwent non-invasive deep brain ablation surgery (central lateral thalamotomy) with transcranial TcMRgFUS and showed improvement in pain scores and reduction of pain medication with no adverse effects at three months follow-up. This is the first study in the world to test non-invasive transcranial focused ultrasound as a treatment modality for functional brain disorders.
generic viagra online
Scientists Track Chemical Changes In Cells As They Endure Extreme Conditions
One of nature"s most gripping feats of survival is now better understood. For the first time, scientists from the U.S. Department of Energy"s Lawrence Berkeley National Laboratory observed the chemical changes in individual cells that enable them to survive conditions that should kill them.
News of the day
International Groups Express Concern About Cambodian 'AIDS Colony'
In an open letter to Cambodia"s prime minister and health minister, more than 100 international HIV/AIDS advocates and human rights organizations "accused the Cambodian government of herding HIV-affected families into an "AIDS colony" outside the capital, Phnom Penh," the Guardian reports (McCurry, 7/28).
Public Health

Mac Researchers Find "surprising Link" Leads Towards A New Antibiotic

As the best drugs become increasingly resistant to superbugs, McMaster University researchers have discovered a completely different way of looking for a new antibiotic. In a paper to be published published Friday, May 29 in the journal Chemistry and Biology, with colleagues in Germany and Wilfrid Laurier University, they report on work with the bacteria Staphylococcus aureus bacteria, the leading cause of infections in hospitals and the second most common community-acquired infection. Fewer and fewer antibiotics are effective against this bacteria. Cell wall-active antibiotics, such as penicillin, kill bacteria by blocking production of the cell wall. The researchers provide new evidence for genetic connections among three processes in the cell wall - teichoic acid, peptidoglycan and poly-isoprenoid synthesis. "Never before has such a profound link been drawn between these biosynthetic pathways supported by genetic, computational and biochemical evidence," they said in their paper. "We found a connection that perhaps no one expected in the way the cell wall synthesis is wired," said lead author Eric Brown, professor and chair of the department of biochemistry and biomedical sciences in the Michael G. DeGroote School of Medicine. "We found they are inextricably linked in their genetics and biochemistry," he said. "Along the way in this study, we have built a system that is ripe for being exploited as a way to search for small molecule drugs that would target these processes." Potentially, he said, this may lead to the development of a new antibiotic. Brown said the current arsenal of antibiotics was developed during the golden age of antibiotic drug discovery from 1930 to 1960, and then development stopped. Research began again in earnest, he said, when troublesome strains of hospital and community-acquired infections began to emerge, such as MRSA (methicillin-resistant Staphylococcus aureus). "Since the 1960s, drug companies have for, the most part, been tweaking existing molecules, such as building better penicillin with minor changes to the original scaffold. But, you are not very far away from resistance when all you do is a little tweak." The discovery of a "surprising link" between the three processes involved in cell wall synthesis lets researchers build a method of looking for molecules that will disturb the balance between them. "It offers a completely different way of looking for a new antibiotic that would be active against the cell wall," Brown said. McMaster University


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):